PRESS RELEASES
Archives
December 17, 2015 - OptiNose to Present at the 34th Annual J.P. Morgan Healthcare Conference
October 6, 2015 - OptiNose Closes New Round of Financing
September 24, 2015 - OptiNose Announces Positive Results of Second Phase III Pivotal Trial for OPN-375
July 15, 2015 - OptiNose Announces Positive Early Phase Clinical Trial with OPN-300, an Investigational Product in Development for Treatment of Autism Spectrum Disorders
June 24, 2015 - OptiNose Announces Positive Results of Phase III Trial for OPN-375
March 30, 2015 - OptiNose to Present at Innovations in Healthcare Executive Forum
March 19, 2015 - OptiNose to Present at Nasal and Respiratory Drug Delivery Conferences
February 23, 2015 - OptiNose to Present at the 35th Annual Cowen Healthcare Conference